A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, April 2011

Altmetric Badge

Mentioned by

patent: 18 patents

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 33 Mendeley

So far, Altmetric has seen 18 patents that reference this research output.

A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion

Mentioned by

Citations

Readers on

Method of treating cancer associated with a RAS mutation

Grant US-11918574-B2

United States of America

Compositions containing tucaresol or its analogs

Grant US-11857522-B2

United States of America

Composition and method for reducing thrombocytopenia

Grant US-11786523-B2

United States of America

Tubulin binding compounds and therapeutic use thereof

Grant US-11633393-B2

United States of America

Method of reducing chemotherapy-induced neutropenia

Grant US-11400086-B2

United States of America

Plinabulin compositions

Grant US-11254657-B2

United States of America

Composition and method for reducing neutropenia

Grant US-11229642-B2

United States of America

Method of treating cancer associated with a RAS mutation

Grant US-11045467-B2

United States of America

Compositions containing tucaresol or its analogs

Grant US-10912748-B2

United States of America

Method of treating cancer associated with a RAS mutation

Grant US-10668063-B2

United States of America

Plinabulin compositions

Grant US-10550104-B2

United States of America

Method of treating a brain tumor

Grant US-10357491-B2

United States of America

Method of treating cancer associated with a RAS mutation

Grant US-10238650-B2

United States of America

Plinabulin compositions

Grant US-10155748-B2

United States of America

Compositions and methods of delivery of pharmacological agents

Grant US-9012519-B2

United States of America

Compositions and methods of delivery of pharmacological agents

Grant US-9012518-B2

United States of America

Compositions and methods of delivery of pharmacological agents

Grant US-8846771-B2

United States of America

Compositions and methods of delivery of pharmacological agents

Grant US-8314156-B2

United States of America